UAMS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $14.2M
- Transactions
- 2,347
- Companies
- 40
- Average per transaction
- $6,033
Who reported the payments
| E.r. Squibb & Sons, L.L.C. | $1,357,639 |
| Nevro Corp. | $1,135,389 |
| Janssen Research & Development, LLC | $1,046,969 |
| Vertex | $835,095 |
| Takeda Pharmaceuticals U.S.A., Inc. | $771,756 |
| AbbVie | $591,450 |
| CSL Behring | $562,234 |
| Intuitive Surgical | $491,755 |
| Bristol Myers Squibb | $455,943 |
| Aadi Bioscience, Inc. | $418,459 |
| Genentech, Inc. | $382,521 |
| Pfizer | $304,713 |
| Gilead | $265,350 |
| Amneal Pharmaceuticals LLC | $263,734 |
| Saluda Medical Americas, Inc. | $261,999 |
| Neurocrine Biosciences, Inc. | $218,628 |
| Baxter Healthcare | $218,445 |
| SPR Therapeutics, Inc | $217,651 |
| Amicus Therapeutics, Inc. | $210,586 |
| AstraZeneca | $210,503 |
| Boston Scientific | $202,000 |
| Stryker | $185,250 |
| Medtronic | $158,478 |
| MML US, Inc. | $148,425 |
| Angiodynamics, Inc. | $135,333 |
| EMD Serono, Inc. | $126,421 |
| Sage Therapeutics, LLC | $126,076 |
| Travere Therapeutics, Inc. | $119,660 |
| Biotronik Inc. | $119,261 |
| Merck | $118,129 |
| UCB, Inc. | $106,000 |
| Alnylam Pharmaceuticals Inc. | $102,237 |
| Blueprint Medicines Corporation | $99,536 |
| Medical Device Business Services, Inc. | $79,305 |
| Mallinckrodt Enterprises LLC | $78,390 |
| Exactech, Inc. | $76,885 |
| Intercept Pharmaceuticals, Inc. | $73,485 |
| Abbott | $69,482 |
| Monteris Medical Corporation | $68,635 |
| Exelixis Inc. | $61,859 |